Back

The effect of novel heart failure pharmacotherapies on myocardial fibrosis and inflammasome pathway proteins in myocardial samples of heart failure patients undergoing heart transplantation

17 April 2026 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (1) Leukocytes, Inflammation, Immunity Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor David Nagy

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

35 More presentations in this session

Presentation thumbnail
MicroRNA changes in plasma associated with fibrous coronary plaque remodelling after PCSK9 inhibitor therapy in familial hypercholesterolemia with subclinical atherosclerosis
Doctor O. Escate Chavez (Barcelona, ES)
Abstract
Presentation thumbnail
Meis 1 synergizes with nkx2.5 to repress isl1 transcription
Mrs D. Slenczka (Berlin, DE)
Abstract
Presentation thumbnail
EZH2 controls microRNA expression in T cells in atherosclerosis
Ms X. Li (Munich, DE)
Abstract
Presentation thumbnail
Functional investigation of circular RNAs in cardiomyocyte proliferation and regeneration
Miss S. Ersoy (Hannover, DE)
Abstract
Presentation thumbnail
Role of mir-147 and let-7b in efferocytosis
Ms Q. Meng (Munich, DE)
Abstract

Access the full session

Session thumbnail
Poster session (1)

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

17 April 2026 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources